News & Updates

Treatment with upadacitinib, an oral selective Janus kinase inhibitor, led to greater proportions of days spent with improved nighttime itch and sleep disturbance experienced by patients with moderate-to-severe atopic dermatitis (AD), according to an integrated analysis of the phase III Measure Up 1 and 2 studies presented at AAD 2024.

How children in Singapore meet sleep, screen time, and physical activity recommendations appears to slip as they transition from infants to screen-focused toddlers and preschoolers, according to a study.

Researchers have developed an artificial intelligence (AI)-enabled tool that can automatically detect vital steps during robotic-assisted radical prostatectomy (RARP) with high accuracy.

In patients with Dravet syndrome, treatment with levodopa appears to produce improvements in gait disturbance, as shown in a randomized crossover trial.